 |
Promising New Opregen® Clinical Data Featured At 54th Annual Retina Society Meeting In Podium Presentation By Christopher D. Riemann, M.D.Lineage Cell Therapeutics announced that updated interim results from a Phase 1/2a clinical study of its lead product candidate, OpRegen®, were featured in a podium presentation at the 54th Annual Scientific Meeting of the Retina Society. Research, News & Market Data on Lineage Cell Therapeutics |
 |
EEG’s iGaming Division Hits New Revenue Record, SportNation Nominated for AwardEsports Entertainment Group announced the company and their SportNation.bet business has been nominated for eGaming Review’s Marketing Campaign of the Year Award Research, News & Market Data on EEG |
 |
Orion Group Holdings, Inc. Announces Contract Awards of Nearly $200 MillionOrion Group Holdings announced two contract awards for its Marine segment totaling nearly $200 million See today’s research report from Poe Fratt, Senior Research Analyst at Noble Capital Markets Research, News & Market Data on Orion Group Holdings |
 |
Great Lakes Announces Partnership with Project VestaGreat Lakes Dredge & Dock announced a first-of-its-kind partnership with Project Vesta, a clean technology pioneer developing a new way to use sand to remove excess carbon dioxide from the atmosphere See today’s research report from Poe Fratt, Senior Research Analyst at Noble Capital Markets Research, News & Market Data on Great Lakes |
 |
Sierra Metals Announces Filing of Updated NI 43-101 Technical ReportSierra Metals announced it has filed an updated independent technical report prepared in accordance with National Instrument 43-101 on the Bolivar Mine in Mexico Research, News & Market Data on Sierra Metals |
 |
CanAlaska Identifies New Targets at Kingston Uranium ProjectCanAlaska Uranium announced that compilation work on the Company’s newly acquired Kingston Project has identified several new uranium targets Research, News & Market Data on CanAlaska |
Stay up to date. Follow us:
|